Section Arrow
RVTY.NYSE
- Revvity
Quotes are at least 15-min delayed:2026/01/08 05:59 EST
Pre Market
Last
 --
-- (--)
Bid
94.88
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 102.99
-2.06 (-1.96%)
Day High 
106 
Prev. Close
105.05 
1-M High
106.39 
Volume 
988.54K 
Bid
94.88
Ask
--
Day Low
102.34 
Open
105.21 
1-M Low
95.44 
Market Cap 
11.91B 
Currency 美元 
P/E 54.15 
%Yield 0.34 
10-SMA 98.54 
20-SMA 98.83 
50-SMA 97.38 
52-W High 128.285 
52-W Low 81.36 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.99/6.18
Enterprise Value
15.21B
Balance Sheet
Book Value Per Share
65.06
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
3.31B
Operating Revenue Per Share
24.66
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp7.38-0.03-0.40%879PE
Pre Market 7.38 0 0.00%
OPKOPKO Health1.36+0.04+3.03%-- 
Pre Market 1.36 0 0.00%
DHRDanaher Corp235.57-1.02-0.43%48.68PE
Pre Market 234.71 -0.86 -0.37%
GHGuardant Health109.93-2.4-2.14%-- 
Pre Market 109 -0.93 -0.85%
EXASExact Sciences Corp101.63-0.02-0.02%-- 
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed
Business Description
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.